The functional food ingredient developer reported a significant revenue decline and increased losses in its half-year results, facing production delays and cash flow challenges.
The healthcare company reports a 61% sales increase but an underlying operating loss, and delays publication of its annual accounts, leading to a temporary trading suspension.
The healthcare company has granted options and warrants to management and consultants, representing potential dilution of 12.5% of issued share capital.
Functional food ingredient developer reports soaring sales and strategic wins
The healthcare company has secured additional Fruitflow inventory to meet growing demand and will issue new shares to settle a royalty payment, supporting future production.
Functional food company Provexis reports strong sales growth, but cash concerns linger
Provexis sees sales growth and progress expanding into China
Provexis, the company behind Fruitflow technology, reports a loss for the year and expects to make a further loss in the future. The company may need to raise funds to meet its working capital requirements.